Four sites open in France: CHU Brest, CHU Dijon, Hospital Edouard Herriot in Lyon and CHU St. Etienne.
We are happy to annouce that 3 additional sites beside CHU Brest could be initiated in April and May 2024. We wish the study teams at all four sites good luck for recruiting of trial participants!